Trial Profile
ENBREL Clinical Outcome in RA patients for Growing Evidence.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Etanercept (Primary) ; Disease-modifying antirheumatics; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms ENCOURAGE
- Sponsors Takeda Pharma; TAP Pharmaceuticals
- 30 Apr 2015 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 01 Nov 2011 Status changed from not yet recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 19 Nov 2009 New trial record